1
|
Nayar M, Varghese C, Kanwar A, Siriwardena AK, Haque AR, Awan A, Balakrishnan A, Rawashdeh A, Ivanov B, Parmar C, Halloran CM, Caruana C, Borg CM, Gomez D, Damaskos D, Karavias D, Finch G, Ebied H, Pine JK, Skipworth JRA, Milburn J, Latif J, Apollos J, El Kafsi J, Windsor JA, Roberts K, Wang K, Ravi K, Coats MV, Hollyman M, Phillips M, Okocha M, Wilson MS, Ameer NA, Kumar N, Shah N, Lapolla P, Magee C, Al-Sarireh B, Lunevicius R, Benhmida R, Singhal R, Balachandra S, Demirli Atıcı S, Jaunoo S, Dwerryhouse S, Boyce T, Charalampakis V, Kanakala V, Abbas Z, Tewari N, Pandanaboyana S. SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study. Gut 2022; 71:1444-1447. [PMID: 34764192 DOI: 10.1136/gutjnl-2021-326218] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Accepted: 10/05/2021] [Indexed: 01/08/2023]
Affiliation(s)
- Manu Nayar
- HPB Unit, Freeman Hospital, Newcastle upon Tyne, UK
- UK
| | - Chris Varghese
- Faculty of Medical and Health Sciences, Department of Surgery, The University of Auckland, Auckland, New Zealand
| | - Aditya Kanwar
- University Hospitals Plymouth NHS Trust, Plymouth, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | - Guy Finch
- Northampton General Hospital, Northampton, UK
| | | | | | | | | | | | | | | | | | | | - Kelvin Wang
- Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, UK
| | - Krish Ravi
- Chesterfield Royal Hospital NHS Trust, Chesterfield, UK
| | | | | | | | | | | | - Nadeem A Ameer
- University Hospital of Coventry and Warwickshire, Coventry, UK
| | | | - Nehal Shah
- Northern General Hospital, Sheffield, UK
| | | | | | | | | | | | - Rishi Singhal
- University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
| | | | - Semra Demirli Atıcı
- Department of General Surgery, University of Health Sciences Tepecik Training and Research Hospital, İzmir, Turkey
| | | | | | | | | | | | - Zaigham Abbas
- Dr. Ziauddin University Hospital, Clifton Karachi, Pakistan
| | | | - Sanjay Pandanaboyana
- HPB and Transplant Unit, Freeman Hospital, Newcastle upon Tyne, UK
- Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK
| |
Collapse
|
2
|
Pandanaboyana S, Moir J, Leeds JS, Oppong K, Kanwar A, Marzouk A, Belgaumkar A, Gupta A, Siriwardena AK, Haque AR, Awan A, Balakrishnan A, Rawashdeh A, Ivanov B, Parmar C, M Halloran C, Caruana C, Borg CM, Gomez D, Damaskos D, Karavias D, Finch G, Ebied H, K Pine J, R A Skipworth J, Milburn J, Latif J, Ratnam Apollos J, El Kafsi J, Windsor JA, Roberts K, Wang K, Ravi K, V Coats M, Hollyman M, Phillips M, Okocha M, Sj Wilson M, A Ameer N, Kumar N, Shah N, Lapolla P, Magee C, Al-Sarireh B, Lunevicius R, Benhmida R, Singhal R, Balachandra S, Demirli Atıcı S, Jaunoo S, Dwerryhouse S, Boyce T, Charalampakis V, Kanakala V, Abbas Z, Nayar M. SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study. Gut 2021; 70:1061-1069. [PMID: 33547182 PMCID: PMC7871229 DOI: 10.1136/gutjnl-2020-323364] [Citation(s) in RCA: 55] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Revised: 01/04/2021] [Accepted: 01/11/2021] [Indexed: 02/07/2023]
Abstract
OBJECTIVE There is emerging evidence that the pancreas may be a target organ of SARS-CoV-2 infection. This aim of this study was to investigate the outcome of patients with acute pancreatitis (AP) and coexistent SARS-CoV-2 infection. DESIGN A prospective international multicentre cohort study including consecutive patients admitted with AP during the current pandemic was undertaken. Primary outcome measure was severity of AP. Secondary outcome measures were aetiology of AP, intensive care unit (ICU) admission, length of hospital stay, local complications, acute respiratory distress syndrome (ARDS), persistent organ failure and 30-day mortality. Multilevel logistic regression was used to compare the two groups. RESULTS 1777 patients with AP were included during the study period from 1 March to 23 July 2020. 149 patients (8.3%) had concomitant SARS-CoV-2 infection. Overall, SARS-CoV-2-positive patients were older male patients and more likely to develop severe AP and ARDS (p<0.001). Unadjusted analysis showed that SARS-CoV-2-positive patients with AP were more likely to require ICU admission (OR 5.21, p<0.001), local complications (OR 2.91, p<0.001), persistent organ failure (OR 7.32, p<0.001), prolonged hospital stay (OR 1.89, p<0.001) and a higher 30-day mortality (OR 6.56, p<0.001). Adjusted analysis showed length of stay (OR 1.32, p<0.001), persistent organ failure (OR 2.77, p<0.003) and 30-day mortality (OR 2.41, p<0.04) were significantly higher in SARS-CoV-2 co-infection. CONCLUSION Patients with AP and coexistent SARS-CoV-2 infection are at increased risk of severe AP, worse clinical outcomes, prolonged length of hospital stay and high 30-day mortality.
Collapse
Affiliation(s)
- Sanjay Pandanaboyana
- HPB Unit, Freeman Hospital, Newcastle upon Tyne, UK
- Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK
| | - John Moir
- HPB Unit, Freeman Hospital, Newcastle upon Tyne, UK
| | - John S Leeds
- HPB Unit, Freeman Hospital, Newcastle upon Tyne, UK
- Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK
| | - Kofi Oppong
- HPB Unit, Freeman Hospital, Newcastle upon Tyne, UK
- Translational and Clinical Research Institute, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
| | - Aditya Kanwar
- University Hospitals Plymouth NHS Trust, Plymouth, UK
| | | | | | - Ajay Gupta
- South Bristol Community hospital, Bristol, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | - Guy Finch
- Northampton General Hospital, Northampton, UK
| | | | | | | | | | | | | | | | | | | | - Kelvin Wang
- Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, UK
| | - Krish Ravi
- Chesterfield Royal Hospital NHS Trust, Chesterfield, UK
| | | | | | | | | | | | - Nadeem A Ameer
- University Hospital of Coventry and Warwickshire, Coventry, UK
| | | | - Nehal Shah
- Northern General Hospital, Sheffield, UK
| | | | | | | | | | | | - Rishi Singhal
- University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
| | | | - Semra Demirli Atıcı
- University of Health Sciences Tepecik Training and Research Hospital, Department of General Surgery, İzmir, Turkey
| | - Shameen Jaunoo
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | | | | | | | | | - Zaigham Abbas
- Dr Ziauddin University Hospital, Clifton Karachi, Pakistan
| | - Manu Nayar
- HPB Unit, Freeman Hospital, Newcastle upon Tyne, UK
- Translational and Clinical Research Institute, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
| |
Collapse
|